Sms Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 8.47 Cr
as on 08-12-2024
- Company Age 37 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 652.63 Cr
as on 08-12-2024
- Satisfied Charges ₹ 510.70 Cr
as on 08-12-2024
- Revenue -7.33%
(FY 2022)
- Profit 11.60%
(FY 2022)
- Ebitda -5.47%
(FY 2022)
- Net Worth 15.30%
(FY 2022)
- Total Assets 6.39%
(FY 2022)
About Sms Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532815 and on the National Stock Exchange(NSE) under SMSPHARMA.
The Corporate was formerly known as Sms Pharmaceuticals Pvt Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 8.47 Cr.
The company currently has active open charges totaling ₹652.63 Cr. The company has closed loans amounting to ₹510.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sms Pharmaceuticals Limited India are Lakshmi Tammineedi as CFO and Mr Tumma as Company Secretary. Ramesh Potluri, Gangavarapu Kumar, Srinivas Sarvepalli, and Five other members serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sms Pharmaceuticals Limited offer?
Sms Pharmaceuticals Limited offers a wide range of products and services, including Environment Protection & Auditing, Environment Protection Services, API Intermediate, Risperidone Intermediates, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Sms Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Potluri  | Managing Director | 01-Dec-2008 | Current |
| Lakshmi Tammineedi | CFO | 13-Sep-2017 | Current |
| Mr Tumma | Company Secretary | 16-Feb-2022 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vamsi Potluri | Whole-Time Director | 05-Jun-2020 | Current |
| Trilok Potluri | Director | 12-Aug-2024 | Current |
| Gangavarapu Kumar | Director | 12-Aug-2024 | Current |
| Srinivas Sarvepalli | Director | 12-Aug-2019 | Current |
| Shravan Kudaravalli | Director | 26-May-2018 | Current |
| Shanti Bolleni | Director | 12-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Sms Pharmaceuticals.
Sms Pharmaceuticals Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.33% decrease. The company also saw a substantial improvement in profitability, with a 11.6% increase in profit. The company's net worth Soared by an impressive increase of 15.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sms Pharmaceuticals?
In 2022, Sms Pharmaceuticals had a promoter holding of 67.29% and a public holding of 32.71%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Feb 2024 | ₹100.00 Cr | Open |
Others Creation Date: 02 Nov 2023 | ₹130.00 Cr | Open |
Idbi Bank Limited Creation Date: 24 Jan 2023 | ₹25.00 Cr | Open |
How Many Employees Work at Sms Pharmaceuticals?
Sms Pharmaceuticals has a workforce of 1193 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sms Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sms Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
